Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190294 | 0.98 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1038114 | 0.98 | LMNA (0.42) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL11097713 | 0.96 | LMNA (0.43) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL11099490 | 0.92 | LMNA (0.46) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Avridine SCHEMBL6741009 | 0.89 | LMNA (0.35) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL268149 | 0.86 | DNM1 (0.39) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| Fluoride SCHEMBL30636245 | 0.80 | LMNA (0.43) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL10994980 | 0.79 | LMNA (0.44) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1970702 | 0.79 | LMNA (0.44) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL31099214 | 0.78 | LMNA (0.39) | LMNAALDH1A1HSD17B10MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100260849-A1 | REMINERALIZING COMPOSITIONS AND METHODS | 3M INNOVATIVE PROPERTIES COMPANY | 2010-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100260849-A1 | REMINERALIZING COMPOSITIONS AND METHODS | CA3, CA2, CA1 | LMNA 824/4885ALDH1A1 4491/4885HSD17B10 4109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.